Oncology

  1. Zejula (niraparib)
    Zejula (niraparib)
    by Tesaro UK Limited
    for Gynaecological Cancer
    €7,990.00
  2. Tecentriq (atezolizumab)
    Tecentriq (atezolizumab)
    by Roche Registration Limited
    for Urothelial Carcinoma, Lung Cancer
    €6,319.25
  3. Tagrisso (osimertinib)
    Tagrisso (osimertinib)
    by AstraZeneca AB
    for Lung Cancer
    €8,619.25
  4. Rydapt (midostaurin)
    Rydapt (midostaurin)
    by Novartis Europharm Limited
    for Leukemia
    €20,717.25
  5. Rubraca (rucaparib)
    Rubraca (rucaparib)
    by Clovis Oncology, Inc.
    for Gynaecological Cancer
    €10,982.50
  6. Portrazza (necitumumab)
    Portrazza (necitumumab)
    by Eli Lilly Nederland B.V.
    for Lung Cancer
    €638.25
  7. Perjeta (pertuzumab)
    Perjeta (pertuzumab)
    by Roche Registration Limited
    for Breast Cancer
    €2,869.25
  8. Opdivo (nivolumab)
    Opdivo (nivolumab)
    by Bristol-Myers Squibb Pharma EEIG
    for Urothelial Carcinoma, Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer
    €498.00
  9. Onivyde (irinotecan hydrochloride trihydrate)
    Onivyde (irinotecan hydrochloride trihydrate)
    by Baxalta Innovations GmbH
    for Pancreatic Cancer
    €1,075.25
View as Grid List

Items 1-9 of 32

Page
per page
Set Descending Direction